{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:30:58Z","timestamp":1782271858507,"version":"3.54.5"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-026-02552-2","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:25:25Z","timestamp":1773930325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Innovating global regulatory frameworks for generative AI in medical devices is an urgent priority"],"prefix":"10.1038","volume":"9","author":[{"given":"Jasmine Chiat Ling","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldev","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C. W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Siu Kwan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Freyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle S.","family":"Bitterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair K.","family":"Denniston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2552_CR1","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41591-022-01993-y","volume":"28","author":"MY Ng","year":"2022","unstructured":"Ng, M. Y., Kapur, S., Blizinsky, K. D. & Hernandez-Boussard, T. The AI life cycle: a holistic approach to creating ethical AI for health decisions. Nat. Med. 28, 2247\u20132249 (2022).","journal-title":"Nat. Med."},{"key":"2552_CR2","doi-asserted-by":"publisher","first-page":"890809","DOI":"10.3389\/fcvm.2022.890809","volume":"9","author":"E Wellnhofer","year":"2022","unstructured":"Wellnhofer, E. Real-world and regulatory perspectives of artificial intelligence in cardiovascular imaging. Front. Cardiovasc. Med. 9, 890809 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"2552_CR3","unstructured":"Food and Drug Administration, U.S.A. Total product lifecycle considerations for generative AI-enabled devices. in Executive Summary for the Digital Health Advisory Committee (FDA, 2024); https:\/\/www.fda.gov\/media\/182871\/download."},{"key":"2552_CR4","doi-asserted-by":"publisher","first-page":"241\u2013","DOI":"10.1001\/jama.2024.21451","volume":"333","author":"HJ Warraich","year":"2024","unstructured":"Warraich, H. J., Tazbaz, T. & Califf, R. M. FDA perspective on the regulation of artificial intelligence in health care and biomedicine. JAMA 333, 241\u2013247 (2024).","journal-title":"JAMA"},{"key":"2552_CR5","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S2589-7500(24)00061-X","volume":"6","author":"JCL Ong","year":"2024","unstructured":"Ong, J. C. L. et al. Ethical and regulatory challenges of large language models in medicine. Lancet Digit. Health 6, e428\u2013e432 (2024).","journal-title":"Lancet Digit. Health"},{"key":"2552_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41746-024-01232-3","volume":"7","author":"M Aboy","year":"2024","unstructured":"Aboy, M., Minssen, T. & Vayena, E. Navigating the EU AI act: implications for regulated digital medical products. NPJ Digit. Med. 7, 237 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jama.2024.21700","volume":"333","author":"S Bedi","year":"2025","unstructured":"Bedi, S. et al. Testing and evaluation of health care applications of large language models: a systematic review. JAMA 333, 319\u2013328 (2025).","journal-title":"JAMA"},{"key":"2552_CR8","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1038\/s41591-025-03727-2","volume":"31","author":"S Sandmann","year":"2025","unstructured":"Sandmann, S. et al. Benchmark evaluation of DeepSeek large language models in clinical decision-making. Nat. Med. 31, 2546\u20132549 (2025).","journal-title":"Nat. Med."},{"key":"2552_CR9","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1038\/s41591-024-03097-1","volume":"30","author":"P Hager","year":"2024","unstructured":"Hager, P. et al. Evaluation and mitigation of the limitations of large language models in clinical decision-making. Nat. Med. 30, 2613\u20132622 (2024).","journal-title":"Nat. Med."},{"key":"2552_CR10","unstructured":"Nori, H. et al. Sequential diagnosis with language models. Preprint https:\/\/arxiv.org\/abs\/2506.22405 (2025)."},{"key":"2552_CR11","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1038\/s41591-024-03258-2","volume":"30","author":"SR Pfohl","year":"2024","unstructured":"Pfohl, S. R. et al. A toolbox for surfacing health equity harms and biases in large language models. Nat. Med. 30, 3590\u20133600 (2024).","journal-title":"Nat. Med."},{"key":"2552_CR12","unstructured":"Alber, D. A. et al. Medical large language models are vulnerable to data-poisoning attacks. Nat. Med. 31, 1\u20139 (2025)."},{"key":"2552_CR13","doi-asserted-by":"publisher","first-page":"100196","DOI":"10.1016\/j.mcpdig.2025.100196","volume":"3","author":"O Freyer","year":"2025","unstructured":"Freyer, O., Wiest, I. C. & Gilbert, S. Policing the boundary between responsible and irresponsible placing on the market of LLM health applications. Mayo Clin. Proc. Digit. Health 3, 100196 (2025).","journal-title":"Mayo Clin. Proc. Digit. Health"},{"key":"2552_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s42256-024-00878-8","volume":"6","author":"S Longpre","year":"2024","unstructured":"Longpre, S. et al. A large-scale audit of dataset licensing and attribution in AI. Nat. Mach. Intell. 6, 975\u2013987 (2024).","journal-title":"Nat. Mach. Intell."},{"key":"2552_CR15","doi-asserted-by":"publisher","first-page":"e214622","DOI":"10.1001\/jamanetworkopen.2021.4622","volume":"4","author":"JE Peter","year":"2021","unstructured":"Peter, J. E. Algorithmovigilance-advancing methods to analyze and monitor artificial intelligence-driven health care for effectiveness and equity. JAMA Netw. Open 4, e214622 (2021).","journal-title":"JAMA Netw. Open"},{"key":"2552_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01237-y","volume":"7","author":"B Alan","year":"2024","unstructured":"Alan, B., Mehdi, B., Theodoros, E. & Philippe, R. Algorithmovigilance, lessons from pharmacovigilance. NPJ Digit. Med. 7, 270 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.5005\/jp-journals-10071-23951","volume":"25","author":"A Vandana","year":"2021","unstructured":"Vandana, A. Off-label medication use: a double-edged sword. Indian J. Crit. Care Med. 25, 845\u2013846 (2021).","journal-title":"Indian J. Crit. Care Med."},{"key":"2552_CR18","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.4103\/0976-500X.120955","volume":"4","author":"P Caterina","year":"2013","unstructured":"Caterina, P. et al. Limitations and obstacles of the spontaneous adverse drugs reactions reporting: two \u201cchallenging\u201d case reports. J. Pharmacol. Pharmacother 4, S66\u2013S72 (2013).","journal-title":"J. Pharmacol. Pharmacother"},{"key":"2552_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00228-008-0475-9","volume":"64","author":"L Harmark","year":"2008","unstructured":"Harmark, L. & van Grootheest, A. C. Pharmacovigilance: methods, recent developments and future perspectives. Eur. J. Clin. Pharmacol. 64, 743\u2013752 (2008).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2552_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2146\/ajhp151031","volume":"74","author":"K Atul","year":"2017","unstructured":"Atul, K. Pharmacovigilance: importance, concepts, and processes. Am. J. Health Syst. Pharm. 74, 606\u2013612 (2017).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"2552_CR21","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/S2589-7500(20)30292-2","volume":"3","author":"JM Urs","year":"2021","unstructured":"Urs, J. M., Paola, D. & Kerstin, N. V. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. Lancet Digit. Health 3, e195\u2013e203 (2021).","journal-title":"Lancet Digit. Health"},{"key":"2552_CR22","doi-asserted-by":"publisher","first-page":"e0283442","DOI":"10.1371\/journal.pone.0283442","volume":"18","author":"L Charlotte","year":"2023","unstructured":"Charlotte, L. & Sandra, R. Identification of predicate creep under the 510(k) process: a case study of a robotic surgical device. PLoS One 18, e0283442 (2023).","journal-title":"PLoS One"},{"key":"2552_CR23","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1016\/S2589-7500(23)00126-7","volume":"5","author":"JM Urs","year":"2023","unstructured":"Urs, J. M., Christain, B. & Kerstin, N. V. FDA-cleared artificial intelligence and machine learning-based medical devices and their 510(k) predicate networks. Lancet Digit. Health 5, e618\u2013e626 (2023).","journal-title":"Lancet Digit. Health"},{"key":"2552_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jama.2022.23279","volume":"329","author":"T Kushal","year":"2023","unstructured":"Kushal, T. et al. Use of recalled devices in new device authorizations under the US Food and Drug Administration\u2019s 510(k) pathway and risk of subsequent recalls. JAMA 329, 136\u2013143 (2023).","journal-title":"JAMA"},{"key":"2552_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01029-4","volume":"7","author":"W Li","year":"2024","unstructured":"Li, W. et al. Prompt engineering in consistency and reliability with the evidence-based guideline for LLMs. npj Digit. Med. 7, 41 (2024).","journal-title":"npj Digit. Med."},{"key":"2552_CR26","doi-asserted-by":"publisher","first-page":"e50638","DOI":"10.2196\/50638","volume":"25","author":"M Bertalan","year":"2023","unstructured":"Bertalan, M. Prompt engineering as an important emerging skill for medical professionals: tutorial. J. Med. Internet Res. 25, e50638 (2023).","journal-title":"J. Med. Internet Res."},{"key":"2552_CR27","doi-asserted-by":"crossref","unstructured":"Ke, Y. H. et al. Retrieval augmented generation for 10 large language models and its generalizability in assessing medical fitness. Npj Digit. Med. 8, 187 (2025).","DOI":"10.1038\/s41746-025-01519-z"},{"key":"2552_CR28","doi-asserted-by":"crossref","unstructured":"Ong, J. C. L. et al. Large language model as clinical decision support system augments medicationsafety in 16 clinical specialties. Cell Rep. Med. 6, 102323 (2025).","DOI":"10.1016\/j.xcrm.2025.102323"},{"key":"2552_CR29","unstructured":"Ng A. DeepLearning.AI. Falling LLM Token Prices and What They Mean for AI Companies https:\/\/www.deeplearning.ai\/the-batch\/falling-llm-token-prices-and-what-they-mean-for-ai-companies\/ (2024)."},{"key":"2552_CR30","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1016\/S2589-7500(24)00124-9","volume":"6","author":"O Freyer","year":"2024","unstructured":"Freyer, O. et al. A future role for health applications of large language models depends on regulators enforcing safety standards. Lancet Digit. Health 6, e662\u2013e672 (2024).","journal-title":"Lancet Digit. Health"},{"key":"2552_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41746-024-01239-w","volume":"7","author":"Z Gongbo","year":"2024","unstructured":"Gongbo, Z. et al. Closing the gap between open source and commercial large language models for medical evidence summarization. NPJ Digit. Med. 7, 239 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR32","doi-asserted-by":"crossref","unstructured":"Wu, S. et al. Benchmarking open-source large language models, GPT-4 and Claude 2 on multiple-choice questions in nephrology. NEJM AI 1, 2 (2024).","DOI":"10.1056\/AIdbp2300092"},{"key":"2552_CR33","doi-asserted-by":"publisher","unstructured":"Ong, J. C. L. et al. Medical ethics of large language models in medicine. NEJM AI. 1, https:\/\/doi.org\/10.1056\/AIra2400038 (2024).","DOI":"10.1056\/AIra2400038"},{"key":"2552_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-023-00939-z","volume":"6","author":"JA Omiye","year":"2023","unstructured":"Omiye, J. A., Lester, J. C., Spichak, S., Rotemberg, V. & Daneshjou, R. Large language models propagate race-based medicine. NPJ Digit. Med. 6, 1\u20134 (2023).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR35","doi-asserted-by":"crossref","unstructured":"Soroush, A. et al. Large language models are poor medical coders\u2014benchmarking of medical code querying. NEJM AI 1, 5 (2024).","DOI":"10.1056\/AIdbp2300040"},{"key":"2552_CR36","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/S2589-7500(23)00225-X","volume":"6","author":"T Zack","year":"2024","unstructured":"Zack, T. et al. Assessing the potential of GPT-4 to perpetuate racial and gender biases in health care: a model evaluation study. Lancet Digit. Health 6, e12\u2013e22 (2024).","journal-title":"Lancet Digit. Health"},{"key":"2552_CR37","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/S2589-7500(20)30187-4","volume":"2","author":"SB Danielle","year":"2020","unstructured":"Danielle, S. B., Hugo, J. W. L. A. & Raymond, H. M. Approaching autonomy in medical artificial intelligence. Lancet Digit. Health 2, e447\u2013e449 (2020).","journal-title":"Lancet Digit. Health"},{"key":"2552_CR38","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1038\/s41591-022-01987-w","volume":"28","author":"G Shaswath","year":"2022","unstructured":"Shaswath, G. et al. Tackling bias in AI health datasets through the STANDING together initiative. Nat. Med. 28, 2232\u20132233 (2022).","journal-title":"Nat. Med."},{"key":"2552_CR39","doi-asserted-by":"crossref","unstructured":"Mirja, M., Marium M. R. & Joseph C. K. Bias in AI-based models for medical applications: challenges and mitigation strategies. NPJ Digit. Med. 6, 113 (2023).","DOI":"10.1038\/s41746-023-00858-z"},{"key":"2552_CR40","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.oret.2022.03.019","volume":"6","author":"ZL Teo","year":"2022","unstructured":"Teo, Z. L. & Ting, D. S. W. Federated learning in ophthalmology: retinopathy of prematurity. Ophthalmol. Retin. 6, 647\u2013649 (2022).","journal-title":"Ophthalmol. Retin."},{"key":"2552_CR41","doi-asserted-by":"crossref","unstructured":"Jiang, J., Liu, X. & Fan, C. Low-parameter federated learning with large language models. Web Information Systems and Applications: 21st International Conference, WISA, 2024 Yinchuan, China 319\u2013330 (2024).","DOI":"10.1007\/978-981-97-7707-5_28"},{"issue":"5","key":"2552_CR42","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/S2589-7500(21)00055-8","volume":"3","author":"TE Tan","year":"2021","unstructured":"Tan, T. E. et al. Retinal photograph-based deep learning algorithms for myopia and a blockchain platform to facilitate artificial intelligence medical research: a retrospective multicohort study. Lancet Digit. Health 3(5), e317\u2013e329 (2021).","journal-title":"Lancet Digit. Health"},{"key":"2552_CR43","unstructured":"Food and Drug Administration. U.S.A. Focus Areas of Regulatory Science\u2014Introduction (FDA, 2024); https:\/\/www.fda.gov\/science-research\/focus-areas-regulatory-science-report\/focus-areas-regulatory-science-introduction"},{"key":"2552_CR44","doi-asserted-by":"crossref","unstructured":"Grandis, G. D., Brass, I. & Farid, S. S. Is regulatory innovation fit for purpose? A case study of adaptive regulation for advanced biotherapeutics. Regul. Govern. 17, 810\u2013832 (2023).","DOI":"10.1111\/rego.12496"},{"key":"2552_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/cpt.59","volume":"97","author":"HG Eichler","year":"2015","unstructured":"Eichler, H. G. et al. From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. Clin. Pharmacol. Ther. 97, 234\u2013246 (2015).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2552_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s40258-021-00665-1","volume":"19","author":"L Emily","year":"2021","unstructured":"Emily, L., Dalia, D., Jacoline, B. & Pall, J. The sandbox approach and its potential for use in health technology assessment: a literature review. Appl. Health Econ. Health Policy 19, 857\u2013869 (2021).","journal-title":"Appl. Health Econ. Health Policy"},{"key":"2552_CR47","unstructured":"Infocomm Media Development Authority, Singapore. Privacy Enhancing Technology Sandboxes\u2014Infocomm Media Development Authority https:\/\/www.imda.gov.sg\/how-we-can-help\/data-innovation\/privacy-enhancing-technology-sandboxes (2024)."},{"key":"2552_CR48","unstructured":"OECD. Regulatory Sandboxes in Artificial Intelligence, Vol. 356 (OECD Digital Economy Papers, 2023)."},{"key":"2552_CR49","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s42256-024-00944-1","volume":"6","author":"J Qiu","year":"2024","unstructured":"Qiu, J. et al. LLM-based agentic systems in medicine and healthcare. Nat. Mach. Intell. 6, 1418\u20131420 (2024).","journal-title":"Nat. Mach. Intell."},{"key":"2552_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-024-01083-y","volume":"7","author":"N Mehandru","year":"2024","unstructured":"Mehandru, N. et al. Evaluating large language models as agents in the clinic. NPJ Digit. Med. 7, 1\u20133 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR51","unstructured":"OpenAI. Learning to Reason with LLMs. Vol. 16 December 2024 (https:\/\/openai.com\/index\/learning-to-reason-with-llms\/, September 12, 2024)."},{"key":"2552_CR52","unstructured":"Lim J. C. W., Tan Koi W. C. & Vogel, S. Regulating the Future of Health: CoRE\u2019s Tenth Anniversary Perspective. in CoRE Regulatory Perspective, Vol. 2024 (Duke-NUS Medical School, Centre of Regulatory Excellence, 2024); https:\/\/www.duke-nus.edu.sg\/core\/think-tank\/core-regulatory-perspective\/regulating-the-future-of-health-core-s-tenth-anniversary-perspective"},{"key":"2552_CR53","unstructured":"Association, A. H. CrowdStrike Technology Outage Causing Global Disruption, Including Impacts on Hospitals (AHA, 2024); https:\/\/www.aha.org\/advisory\/2024-07-19-crowdstrike-technology-outage-causing-global-disruption-across-industries-including-impacts-hospitals-and"},{"key":"2552_CR54","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/s23042131","volume":"4","author":"A Biglari","year":"2023","unstructured":"Biglari, A. & Wei, T. A review of embedded machine learning based on hardware, application, and sensing scheme. Sensors 4, 2131 (2023).","journal-title":"Sensors"},{"key":"2552_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41746-024-01344-w","volume":"7","author":"L Riedemann","year":"2024","unstructured":"Riedemann, L., Labonne, M. & Gilbert, S. The path forward for large language models in medicine is open. NPJ Digit. Med. 7, 339 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR56","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.omtn.2023.08.009","volume":"33","author":"C Chiranjib","year":"2023","unstructured":"Chiranjib, C., Manojit, B. & Sang-Soo, L. Artificial intelligence enabled ChatGPT and large language models in drug target discovery, drug discovery, and development. Mol. Ther. Nucleic Acids 33, 866\u2013868 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2552_CR57","doi-asserted-by":"publisher","first-page":"e2414139","DOI":"10.1001\/jamanetworkopen.2024.14139","volume":"7","author":"LC Druedahl","year":"2024","unstructured":"Druedahl, L. C. et al. Use of artificial intelligence in drug development. JAMA Network Open 7, e2414139 (2024).","journal-title":"JAMA Network Open"},{"key":"2552_CR58","doi-asserted-by":"publisher","first-page":"103992","DOI":"10.1016\/j.drudis.2024.103992","volume":"29","author":"G Amit","year":"2024","unstructured":"Amit, G. & Antonio, L. Unleashing the power of generative AI in drug discovery. Drug Discov. Today 29, 103992 (2024).","journal-title":"Drug Discov. Today"},{"key":"2552_CR59","doi-asserted-by":"crossref","unstructured":"Swanson, K. et al. ADMET-AI: a machine learning ADMET platform for evaluation of large-scalechemical libraries. Bioinformatics 40, btae416 (2024).","DOI":"10.1093\/bioinformatics\/btae416"},{"key":"2552_CR60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41746-025-01565-7","volume":"8","author":"JCL Ong","year":"2025","unstructured":"Ong, J. C. L. et al. A scoping review on generative AI and large language models in mitigating medication related harm. NPJ Digit. Med. 8, 182 (2025).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR61","unstructured":"International Medical Device Regulators Forum. Working Groups: Artificial Intelligence\/Machine Learning-enabled, Vol. 2024 (IMDRF, 2024); https:\/\/www.imdrf.org\/working-groups\/artificial-intelligencemachine-learning-enabled"},{"key":"2552_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01258-7","volume":"7","author":"YCT Thomas","year":"2024","unstructured":"Thomas, Y. C. T. et al. A framework for human evaluation of large language models in healthcare derived from literature review. NPJ Digit. Med. 7, 258 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR63","doi-asserted-by":"publisher","first-page":"e2227779","DOI":"10.1001\/jamanetworkopen.2022.27779","volume":"5","author":"HL Jonathan","year":"2022","unstructured":"Jonathan, H. L. et al. Assessment of adherence to reporting guidelines by commonly used clinical prediction models from a single vendor: a systematic review. JAMA Netw. open 5, e2227779 (2022).","journal-title":"JAMA Netw. open"},{"key":"2552_CR64","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1038\/s41591-023-02608-w","volume":"29","author":"A Anmol","year":"2023","unstructured":"Anmol, A. et al. The value of standards for health datasets in artificial intelligence-based applications. Nat. Med. 29, 2929\u20132938 (2023).","journal-title":"Nat. Med."},{"key":"2552_CR65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41591-024-03425-5","volume":"31","author":"J Gallifant","year":"2025","unstructured":"Gallifant, J. et al. The TRIPOD-LLM reporting guideline for studies using large language models. Nat. Med. 31, 60\u201369 (2025).","journal-title":"Nat. Med."},{"key":"2552_CR66","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41591-020-1037-7","volume":"26","author":"S Cruz Rivera","year":"2020","unstructured":"Cruz Rivera, S. et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension. Nat. Med. 26, 1351\u20131363 (2020).","journal-title":"Nat. Med."},{"key":"2552_CR67","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41591-020-1034-x","volume":"26","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat. Med. 26, 1364\u20131374 (2020).","journal-title":"Nat. Med."},{"key":"2552_CR68","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1016\/S2589-7500(24)00143-2","volume":"6","author":"N Yilin","year":"2024","unstructured":"Yilin, N. et al. Generative artificial intelligence and ethical considerations in health care: a scoping review and ethics checklist. Lancet. Digit. Health 6, e848\u2013e856 (2024).","journal-title":"Lancet. Digit. Health"},{"key":"2552_CR69","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/s41591-024-03310-1","volume":"30","author":"N Yilin","year":"2024","unstructured":"Yilin, N. et al. An ethics assessment tool for artificial intelligence implementation in healthcare: CARE-AI. Nat. Med. 30, 3038\u20133039 (2024).","journal-title":"Nat. Med."},{"key":"2552_CR70","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1001\/jama.2023.26930","volume":"331","author":"HS Nigam","year":"2024","unstructured":"Nigam, H. S. et al. A nationwide network of health AI assurance laboratories. JAMA 331, 245\u2013249 (2024).","journal-title":"JAMA"},{"key":"2552_CR71","unstructured":"Swanson, T. UC Davis Health: Health and Technology. UC Davis Health, NODE.health, and Leading Health Systems launch VALID AI https:\/\/health.ucdavis.edu\/news\/headlines\/uc-davis-health-and-leading-health-systems-launch-valid-ai\/2023\/10 (2023)."},{"key":"2552_CR72","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1038\/s41591-025-03787-4","volume":"31","author":"JCL Ong","year":"2025","unstructured":"Ong, J. C. L. et al. International partnership for governing generative artificial intelligence models in medicine. Nat. Med. 31, 2836\u20132839 (2025).","journal-title":"Nat. Med."},{"key":"2552_CR73","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s42256-023-00699-1","volume":"5","author":"WN Price","year":"2023","unstructured":"Price, W. N., Sendak, M., Balu, S. & Singh, K. Enabling collaborative governance of medical AI. Nat. Mach. Intell. 5, 821\u2013823 (2023).","journal-title":"Nat. Mach. Intell."},{"key":"2552_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01212-7","volume":"7","author":"Y Rui","year":"2024","unstructured":"Rui, Y. et al. Disparities in clinical studies of AI enabled applications from a global perspective. NPJ Digit. Med. 7, 209 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-023-00913-9","volume":"6","author":"D Michael","year":"2023","unstructured":"Michael, D. et al. Considerations for addressing bias in artificial intelligence for health equity. NPJ Digit. Med. 6, 170 (2023).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-024-01198-2","volume":"7","author":"S Br\u00fcckner","year":"2024","unstructured":"Br\u00fcckner, S., Brightwell, C. & Gilbert, S. FDA launches health care at home initiative to drive equity in digital medical care. NPJ Digit. Med. 7, 1\u20133 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR77","doi-asserted-by":"publisher","first-page":"eadn1902","DOI":"10.1126\/scitranslmed.adn1902","volume":"16","author":"WD Kevin","year":"2024","unstructured":"Kevin, W. D. et al. The translational gap for gene therapies in low- and middle-income countries. Sci. Transl. Med. 16, eadn1902 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2552_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00700-y","volume":"5","author":"C-H Tadeusz","year":"2022","unstructured":"Tadeusz, C.-H., Ritvij, S., Miriam, A., Stephan, B. & Sandra, B. Artificial intelligence for strengthening healthcare systems in low- and middle-income countries: a systematic scoping review. NPJ Digit. Med. 5, 162 (2022).","journal-title":"NPJ Digit. Med."},{"key":"2552_CR79","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.xops.2022.100168","volume":"2","author":"M Wanjiku","year":"2022","unstructured":"Wanjiku, M. et al. Impact of artificial intelligence assessment of diabetic retinopathy on referral service uptake in a low-resource setting: the RAIDERS randomized trial. Ophthalmol. Sci. 2, 100168 (2022).","journal-title":"Ophthalmol. Sci."},{"key":"2552_CR80","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/bjo-2022-322683","volume":"108","author":"W Noelle","year":"2024","unstructured":"Noelle, W. et al. Feasibility and acceptance of artificial intelligence-based diabetic retinopathy screening in Rwanda. Br. J. Ophthalmol. 108, 840\u2013845 (2024.","journal-title":"Br. J. Ophthalmol."},{"key":"2552_CR81","unstructured":"Li, J. et al. Integrated image-based deep learning and language models for primary diabetes care. Nat. Med. 30, 1\u201311 (2024)."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02552-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02552-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02552-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:05:50Z","timestamp":1778627150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02552-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02552-2","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors Y.N., L.Z., K.S., R.T.C., S.V., J.C.W.L., I.S.K.T., O.F., D.S.B., X.L. and A.K.D. declare no financial or non-financial competing interests. Author J.C.L.O. serves as associate editor of this journal and had no role in the peer-review or decision to publish this manuscript. Author J.C.L.O. declares no financial competing interests. Author S.G. serves as an editor of this journal and had no role in the peer-review or decision to publish this manuscript. Author S.G. declares no financial competing interests. Author N.L. serves as an editorial board member of this journal and had no role in the peer-review or decision to publish this manuscript. Author N.L. declares no financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}